Bharat Edition

Bharatstox

← All stocks

Gujarat Themis Biosyn Ltd.

NSE: GUJTHEM · Chemicals

Sector

Chemicals

Size band

Small cap

Market cap

2,873cr

P/E

60.1

ROE

33.8%

Dividend yield

0.3%

No price is shown on this page, live or delayed. It records what management said on the earnings call, and the company’s filings.

Measured against

Operating margin48.0%
peer 16.0%
Revenue growth22.2%
peer 23.5%
Gujarat Themis Biosyn Ltd.peer median

Peer set

Specialty Chemicals · 7 measured at Q1 FY27 · financials via Screener
CompanyOperating marginRevenue growth
Hexaware Technologies Ltd.16.0%17.9%
Gujarat Ambuja Exports Ltd.15.0%23.5%
Chemplast Sanmar Ltd.−10.0%2.3%
Gujarat Themis Biosyn Ltd.48.0%22.2%
Bhagiradha Chemicals & Industries Ltd.16.0%57.3%
NGL Fine-Chem Ltd.17.0%33.7%
Dhampur Bio Organics Ltd.1.7%8.3%
OCCL Ltd.28.0%78.9%

No guidance on record.

This section quotes what management told the market on the quarterly earnings call. We have not transcribed one for Gujarat Themis Biosyn Ltd..

No broadcast calls recorded.

We log calls made about a company on business television — Zee Business, CNBC Awaaz and NDTV Profit — as they are stated on air. Nothing is on record for Gujarat Themis Biosyn Ltd..

Filings

latest 25 of 141
  • The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pharmaceutical Business Group India Ltd & Others2 Sept 2026
    High impactM&AFiling PDF ↗
  • Kindly refer to the outcome of the Board Meeting held on 01-09-20261 Sept 2026
    RoutineBoard MeetingFiling PDF ↗
  • Outcome of Board Meeting1 Sept 2026
    RoutineBoard MeetingFiling PDF ↗
  • Committee Meeting Updates28 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of the Fund Raising Committee held on 28.08.2026 for allotment of equity shares through QIP28 Aug 2026
    High impactFundraiseFiling PDF ↗
  • General Updates28 Aug 2026
    High impactFundraiseFiling PDF ↗
  • Outcome of Fund Raising Committee for QIP Issue Close28 Aug 2026
    High impactFundraiseFiling PDF ↗
  • Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2026 ,inter alia, to consider and approve Please refer to the intimation ....27 Aug 2026
    RoutineBoard MeetingFiling PDF ↗
  • General Updates25 Aug 2026
    High impactFundraiseFiling PDF ↗
  • Please refer to the attachment25 Aug 2026
    RoutineGeneralFiling PDF ↗
  • General Updates25 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Please refer to our Announcement under Reg 30 (LODR) - Updates (Audited Financial Statements - F.Y. 2025-26)25 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates14 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Earnings Call Transcript14 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates10 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Investor Presentation7 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Outcome of Board Meeting7 Aug 2026
    RoutineBoard MeetingFiling PDF ↗
  • Analysts/Institutional Investor Meet/Con. Call Updates4 Aug 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under SEBI Takeover Regulations4 Aug 2026
    High impactM&AFiling PDF ↗
  • Shareholders meeting31 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Disclosure under SEBI Takeover Regulations28 Jul 2026
    High impactM&AFiling PDF ↗
  • Copy of Newspaper Publication24 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Shareholders meeting23 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Please refer to the Notice of Postal Ballot 22.07.202623 Jul 2026
    RoutineGeneralFiling PDF ↗
  • Credit Rating- Revision20 Jul 2026
    Medium impactCredit RatingFiling PDF ↗

The 25 most recent of 141 filings we hold for GUJTHEM, back to January 2024. Every filing, by day.

Disclaimer

Guidance is quoted from management commentary on quarterly earnings calls; the words are the company's own and the targets are theirs, not ours. Peer comparisons use quarterly financials sourced from Screener, with every company measured at the same fiscal quarter; the peer set is companies sharing the same industry classification, and comparisons are descriptive, not a ranking or a view. Filings are reproduced as companies filed them to the NSE and BSE; Bharatstox does not verify, endorse or comment on their contents. This page is for informational and educational purposes only and does not constitute investment advice, research, or a recommendation to buy or sell any security. Investing in securities markets is subject to market risks. Read all related documents carefully before investing.

Bharat ke stocks, har subah.

One daily brief on what India's SEBI-registered research analysts are calling. No noise, no spam, unsubscribe whenever.